PTC Therapeutics CBO Eric Pauwels Sells 1,789 Shares in Routine Tax‑Cover Transaction Amid New Drug Approval Flash
PTC insider sales are routine tax‑cover events, not confidence shifts; investors should focus on Sephiencet approvals and pipeline progress.
5 minutes to read